![Theis Kipling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 209 594 $ in data 31/05/2026
Theis Kipling is currently Chief Executive Officer at Biovica International AB since 2026.
Formerly, Mr. Kipling was Chief Commercial Officer at Devyser Diagnostics AB from 2022 to 2026 and Chief Commercial Officer at Atlas Antibodies AB.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2024 | 20.809 ( 0,12% ) | 209 594 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOVICA INTERNATIONAL AB | Amministratore Delegato | 01/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Corporate Officer/Principal | 01/05/2026 |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Biovica International AB
 Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Devyser Diagnostics AB
 Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
